rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2006-2-14
|
pubmed:abstractText |
Doxycycline is the preferred recommended second-line agent for the treatment of syphilis, although efficacy data from controlled trials are lacking. We compared the serological responses of patients with early syphilis treated with doxycycline with the responses of patients treated with benzathine penicillin G (BPG).
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1537-6591
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e45-9
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16477545-Adolescent,
pubmed-meshheading:16477545-Adult,
pubmed-meshheading:16477545-Anti-Bacterial Agents,
pubmed-meshheading:16477545-Doxycycline,
pubmed-meshheading:16477545-Drug Evaluation,
pubmed-meshheading:16477545-Female,
pubmed-meshheading:16477545-Humans,
pubmed-meshheading:16477545-Male,
pubmed-meshheading:16477545-Penicillin G Benzathine,
pubmed-meshheading:16477545-Retrospective Studies,
pubmed-meshheading:16477545-Syphilis,
pubmed-meshheading:16477545-Treatment Outcome
|
pubmed:year |
2006
|
pubmed:articleTitle |
Doxycycline compared with benzathine penicillin for the treatment of early syphilis.
|
pubmed:affiliation |
Johns Hopkins University School of Medicine, Baltimore, MD, USA. kghanem@jhmi.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, N.I.H., Extramural
|